Prescription drug · UNAPPROVED DRUG OTHER
Plexion NDC 57883-404
sulfacetamide sodium, sulfur · Sulfacetamide sodium 98 mg/g; Sulfur 48 mg/g · Cloth · Topical · Brava Pharmaceuticals, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 57883-404-10 | 57883040410 | 10 PACKET in 1 CARTON (57883-404-10) / 4 g in 1 PACKET (57883-404-01)Marketed from Sep 1, 2005 · Sample package | |
| 57883-404-60 | 57883040460 | 60 PACKET in 1 CARTON (57883-404-60) / 4 g in 1 PACKET (57883-404-01)Marketed from Sep 1, 2005 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Plexion
- Generic name (nonproprietary)
- sulfacetamide sodium, sulfur
- Active ingredients
- Sulfacetamide sodium — 98 mg/gSulfur — 48 mg/g
- Dosage form
- Cloth
- Route
- Topical
- Labeler
- Brava Pharmaceuticals, LLC
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Marketing end
- Other FDA classes
- Sulfonamides (Chemical structure)
- Identifiers
- Product ID 57883-404_463d23fc-cb49-0346-e063-6394a90a2df2SPL ID 463d23fc-cb49-0346-e063-6394a90a2df2SPL set ID 8211c8ec-b501-4ac6-8185-b4b9758cdc1aRxCUI 1494170, 1494827UNII 4NRT660KJQ, 70FD1KFU70
- Pharmacologic class
- Sulfonamide Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N457883040410followed by a unit qualifier and the quantityPackage 57883-0404-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE: This product is indicated for use in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.
Excerpt only. Read the full label for complete information.